欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
BE/V/0024/001
药品名称
Clavucill 40mg/ 10mg
活性成分
clavulanic acid 10.0 mg
amoxicillin 40.0 mg
剂型
Tablet
上市许可持有人
V.M.D. nv/sa Hoge Mauw 900 BE-2370 Arendonk Belgium
参考成员国 - 产品名称
Belgium (BE)
Clavucill 40mg/ 10mg
互认成员国 - 产品名称
Germany (DE)
Amoxiclav-VMD 50 mg
Denmark (DK)
Clavucill
Netherlands (NL)
France (FR)
CLAVUCILL 40 MG/10 MG COMPRIMES POUR CHIENS ET CHATS
Spain (ES)
CLAVUCILL 40 MG/10 MG COMPRIMIDOS PARA PERROS Y GATOS
Portugal (PT)
Sweden (SE)
Clavucill
Poland (PL)
Romania (RO)
许可日期
2011/06/22
最近更新日期
2020/11/09
药物ATC编码
QJ01CR02 amoxicillin and beta-lactamase inhibitor
申请类型
TypeLevel1：
[not specified]
TypeLevel2：
[not specified]
TypeLevel3：
Generic - art 13.2 Dir 2001/82/EC
TypeLevel4：
[not specified]
TypeLevel5：
[not specified]
附件文件下载
Final PL
|
Leaflet-en-clavucill-500mg- 10 08 2019
Date of last change:2019/09/30
Final SPC
|
spc-en-clavucill-500mg- 10 08 2019
Date of last change:2019/09/30
Final Labelling
|
Label-en-clavucill-500mg-10 08 2019
Date of last change:2019/09/30
Final Product Information
|
Leaflet-clavucill-250mg-en Clean
Date of last change:2017/11/10
Final Product Information
|
Leaflet-clavucill-50mg-en Clean
Date of last change:2017/11/10
Final Product Information
|
Leaflet-clavucill-500mg-en Clean
Date of last change:2017/11/10
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase